Dr Dispenzieri on the groundbreaking changes in myeloma diagnosis
Dr. Dispenzieri, Professor of Medicine in the Division of Hematology at the Mayo Clinic, discusses the International Myeloma Working Group guidelines for the diagnosis of myeloma, and the new biomarker status of the Freelite assay.
In this video Dr. Dispenzieri talks about:
• Why the new guidelines are groundbreaking
• The role of biomarkers in the new guidelines
• Advice for clinicians
• Implications for patients
View the interview on the groundbreaking changes in myeloma diagnosis